KS-V Peptide has provided peptide services to over 1,000 academic clients and 100 industrial clients from more than 30 countries. We are committed to promoting innovation to support drug research and development, as well as healthy living. At KS-V Peptide, we are excited to collaborate with clients around the world to create innovative partnerships.

KS-V Peptide's proprietary drug discovery and development platform, KPDS™, is designed to discover peptide molecules with high binding and specificity to target proteins or cells, and we are structured to drive three types of innovative peptide-centric therapies:

(1) Peptide and oral peptidomimetic drug molecules

(2) Peptide targeted drug conjugate (PDC & RDC)

(3) Precision Nucleic Acid Drug Delivery with CP-LNP (Cyclic Peptide Conjugated Lipid Nanoparticles)